<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.30743.006</object-id><label>Table 1.</label><caption><title>Experimental data used to fit the model (training set).</title><p>Animals heterozygous for null mutations in <italic>lin-3</italic> or <italic>lin-12</italic> are described in the model by dividing the signal by two (&#8216;half dose&#8217;). The EGF level for one overexpression line (JU1107) was set according to the measured <italic>lin-3</italic> mRNA level. For other perturbations, the change in signal is included as a fitting parameter, cf. Table S2. * Notch null mutations result in the formation of two anchor cells, thus the effect of suppressing Notch signaling between VPCs it not obvious; however, several lines of evidence suggest that it yields the pattern 33133.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" valign="top">Experiment</th><th colspan="5" valign="top">VPC fates (fate or % 1&#176;, 2&#176;, 3&#176;)</th><th rowspan="2" valign="top">References</th></tr><tr><th valign="top">P4.p</th><th valign="top">P5.p</th><th valign="top">P6.p</th><th valign="top">P7.p</th><th valign="top">P8.p</th></tr></thead><tbody><tr><td valign="top">Wild type</td><td valign="top">3&#176;</td><td valign="top">2&#176;</td><td valign="top">1&#176;</td><td valign="top">2&#176;</td><td valign="top">3&#176;</td><td valign="top"/></tr><tr><td colspan="7" valign="top"><bold>EGF/Notch mutants</bold></td></tr><tr><td valign="top"><italic>let-23</italic> mosaic <break/>(no EGF receptors in P5/7 .p)</td><td colspan="5" valign="top">wild type</td><td valign="top">(<xref ref-type="bibr" rid="bib15">Koga and Ohshima, 1995</xref>; <xref ref-type="bibr" rid="bib20">Simske et al., 1995</xref>)</td></tr><tr><td valign="top">Half dose of EGF (<italic>lin-3</italic>/+)</td><td colspan="5" valign="top">wild type</td><td valign="top">(<xref ref-type="bibr" rid="bib6">Ferguson and Horvitz, 1985</xref>)</td></tr><tr><td valign="top">Half dose of Notch (<italic>lin-12</italic>/+)</td><td colspan="5" valign="top">wild type</td><td valign="top">(<xref ref-type="bibr" rid="bib10">Greenwald et al., 1983</xref>)</td></tr><tr><td valign="top">No Notch signaling *</td><td valign="top">3&#176;</td><td valign="top">3&#176;</td><td valign="top">1&#176;</td><td valign="top">3&#176;</td><td valign="top">3&#176;</td><td valign="top">(<xref ref-type="bibr" rid="bib26">Sundaram and Greenwald, 1993</xref>; <break/><xref ref-type="bibr" rid="bib19">Shaye and Greenwald, 2002</xref>; <break/><xref ref-type="bibr" rid="bib16">Komatsu et al., 2008</xref>)</td></tr><tr><td valign="top">Notch null mutant, 2 ACs * <break/>(described as 2&#160;&#215;&#160;WT EGF)</td><td valign="top">3&#176;</td><td valign="top">1&#176;</td><td valign="top">1&#176;</td><td valign="top">1&#176;</td><td valign="top">3&#176;</td><td valign="top">(<xref ref-type="bibr" rid="bib10">Greenwald et al., 1983</xref>)</td></tr><tr><td valign="top"><italic>lin-15</italic> mutant <break/>(ectopic EGF; fit to ~0.4&#160;&#215;&#160;WT)</td><td colspan="5" valign="top">alternating 1&#176; and 2&#176; fates <break/>(with or without AC)</td><td valign="top">(<xref ref-type="bibr" rid="bib24">Sternberg, 1988</xref>)</td></tr><tr><td colspan="7" valign="top"><bold>EGF overexpression</bold></td></tr><tr><td valign="top">JU1107 <break/>2.75&#160;&#215;&#160;WT EGF (based on measured mRNA level)</td><td valign="top">2, 16, 82</td><td valign="top">22, 78, 0</td><td valign="top">100, 0, 0</td><td valign="top">16, 84, 0</td><td valign="top">3, 13, 84</td><td valign="top">(<xref ref-type="bibr" rid="bib2">Barkoulas et al., 2013</xref>)</td></tr><tr><td valign="top">JU1100 <break/>(mRNA level not determined; level fit)</td><td valign="top">24, 54, 21</td><td valign="top">54, 46, 0</td><td valign="top">96, 4, 0</td><td valign="top">37, 63, 0</td><td valign="top">12, 39, 49</td><td valign="top">(<xref ref-type="bibr" rid="bib11">Hoyos et al., 2011</xref>)</td></tr><tr><td colspan="6" valign="top"><bold>AC ablation at successive developmental stages</bold> <break/>(mapped to evenly spaced time points in the model)</td><td valign="top">(<xref ref-type="bibr" rid="bib17">Milloz et al., 2008</xref>)</td></tr><tr><td valign="top">L2 lethargus (<italic>t</italic>&#160;=&#160;0.2)</td><td valign="top"/><td valign="top">3&#176;</td><td valign="top">3&#176;</td><td valign="top">3&#176;</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">early L3 (<italic>t</italic>&#160;=&#160;0.32)</td><td valign="top"/><td valign="top">3, 24, 74</td><td valign="top">18, 19, 64</td><td valign="top">0, 20, 80</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">DU divided (<italic>t</italic>&#160;=&#160;0.44)</td><td valign="top"/><td valign="top">0, 59, 41</td><td valign="top">31, 37, 32</td><td valign="top">0, 53, 47</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">VU divided (<italic>t</italic>&#160;=&#160;0.56)</td><td valign="top"/><td valign="top">0, 95, 5</td><td valign="top">53, 48, 0</td><td valign="top">8, 86, 6</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">3&#176; divided (<italic>t</italic>&#160;=&#160;0.68)</td><td valign="top"/><td valign="top">3, 98, 0</td><td valign="top">65, 35, 0</td><td valign="top">0, 100, 0</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">two-cell stage (<italic>t</italic>&#160;=&#160;0.8)</td><td valign="top"/><td valign="top">1, 99, 0</td><td valign="top">93, 7, 0</td><td valign="top">1, 99, 0</td><td valign="top"/><td valign="top"/></tr><tr><td colspan="6" valign="top"><bold>Epistasis between EGF/Notch</bold></td><td valign="top">(<xref ref-type="bibr" rid="bib2">Barkoulas et al., 2013</xref>)</td></tr><tr><td valign="top">CB1417 <break/>(<italic>lin-3(e1417)</italic> EGF hypomorph; level fit)</td><td valign="top">0, 0, 100</td><td valign="top">0, 10, 90</td><td valign="top">54, 0, 46</td><td valign="top">0, 10, 90</td><td valign="top">0, 0, 100</td><td valign="top"/></tr><tr><td valign="top">JU2064 <break/>(mild ectopic Notch activity; level fit)</td><td valign="top">0, 1, 99</td><td valign="top">0, 100, 0</td><td valign="top">100, 0, 0</td><td valign="top">0, 100, 0</td><td valign="top">1, 2, 97</td><td valign="top"/></tr><tr><td valign="top">JU2095 <break/>(mild ectopic Notch activity in the <italic>lin-3(e1417)</italic> background)</td><td valign="top">0, 0, 100</td><td valign="top">1, 14, 86</td><td valign="top">72, 1, 28</td><td valign="top">0, 16, 84</td><td valign="top">0, 2, 98</td><td valign="top"/></tr></tbody></table></table-wrap>